Bio-IT World News Brief | Pathway Genomics wasted no time after the Supreme Court's ruling on drug patents yesterday. Yesterday the company announced that it would launch a comprehensive cancer panel next-gen sequencing panel including BRCA1 and BRCA2.
|
Bio-IT World | SINGAPORE—At the recent 2013 Bio-IT World Asia conference, scientists and clinicians discussed how they could better coordinate their efforts in clinical genomics and “make genomic information usable in the clinic”.
|
Streamlined, Self-Service Access to Biology and Chemistry Data
Certara
Drug discovery scientists are often challenged in getting the right data to make decisions – chemistry and biological data are stored in different systems, and delivery of data to project teams can require an expert user to manually
|
Bio-IT World Best Practices | In 2011, the leadership in the GlaxoSmithKline’s R&D department made a troubling realization: their scientists were having a tough time finding their data. R&D engineers set about building a new search program that could search through the company’s archived electronic lab notebooks and recognize a vast library of scientific terms. The program’s capabilities earned GSK the 2013 Best Practices Award for Knowledge Management at the Bio-IT World Expo in April.
|
Bio-IT World | SINGAPORE—Sir David Lane kicked off the 2013 Bio-IT World Asia conference this week by describing an alternative paradigm for drug discovery and development: using stapled peptides to target protein-protein interactions.
|
Bio-IT World | Guest Commentary | Transform your business before it’s transformed for you. These words convey a hard truth about modern business—external forces are rapidly conspiring to unravel even the best-laid plans. From geopolitical and economic macro trends to global threats to health and the environment, business change is now maddeningly unpredictable and capricious. Absent a proactive plan to address these new business realities, some businesses are in for challenging futures.
|
Tuesday, May 21, 2013 | BIO IT World | Archives | Advertising | CHI Conferences | Subscribe THIS WEEK IN THE NEWS Small Data Finding Could Help Big Data QualityBio IT World Guest Commentary | I get to have the most fun when someone wants to collaborate on a
|
In the Pipeline | Derek Lowe breaks down how much various companies and sectors spend on R&D. The big spenders? Drug discovery and semiconductor companies.
|
Forbes | Bristol-Myers Squibb's approved drug, Yervoy, is being tested in combination with several experimental drugs to treat advanced melanoma.
|
Tuesday, May 7, 2013 | BIO IT World | Archives | Advertising | CHI Conferences | Subscribe THIS WEEK IN BIO IT WORLD The Model Approach to Drug Development Bio IT World | In a presentation at the Bio IT World Expo last month, Anna Kondic of Merck & Co.
|
Tuesday, April 30, 2013 | BIO IT World | Archives | Advertising | CHI Conferences | Subscribe THIS WEEK IN BIO IT WORLD NIH Seeks New ADDition in a Data Science Director Bio IT World | BETHESDA, MD—With two weeks left to the application deadline, the National Institutes of
|
Tuesday, April 23, 2013 | BIO IT World | Archives | Advertising | CHI Conferences | Subscribe THIS WEEK IN THE NEWS Deanna Church on the Reference Genome Past, Present and Future Bio IT World | Few have spent as much time gazing upon the Reference as Deanna Church
|
Tuesday, April 9, 2013 | BIO IT World | Archives | Advertising | CHI Conferences | Subscribe THIS WEEK IN BIO IT WORLD Early News and Notes from the Expo Floor Bio IT World News Brief | The Bio IT World Conference & Expo begins in Boston this afternoon,
|
Bio-IT World Guest Commentary | I get to have the most fun when someone wants to collaborate on a crazy idea. But crazy ideas come with unexpected challenges, too. Our paper on how dispensing methods affect datasets was published in PLOS ONE a week ago, and we would not have predicted the polarizing effect it has had.
|
Bio-IT World | Amyotrophic lateral sclerosis (ALS) research is getting a major boost from a newly launched Pooled Resource Open-access ALS Clinical Trials (PRO-ACT) platform, which has amassed more than 8,500 de-identified clinical patient records into a single, harmonized dataset. Multiple pharmaceutical companies are now actively exploring PRO-ACT, seeking ways to streamline clinical trials and develop better treatments for the rare and highly heterogeneous disease more commonly known as Lou Gehrig’s disease.
|
Bio-IT World | In a presentation at the Bio-IT World Expo last month, Anna Kondic of Merck & Co. highlighted some recent successes and shortfalls of computer models in the development of cancer drugs.
|
Bio-IT World | Bio-IT World is hosting its second annual Bio-IT World Asia event in Singapore at the end of May—expanded to five tracks. If the plush location at the Marina Bay Sands hotel wasn’t incentive enough, there are four days packed with essential life sciences programming covering IT infrastructure, the cloud, clinical and cancer genomics, bioinformatics and more.
|
|
|
Bio-IT World | BOSTON—In a presentation marked by equal parts melancholy and excitement, Dr. Kevin Hrusovsky spoke at the 2013 Bio-IT World Expo on some of the recent advancements and setbacks in cancer therapeutics.
|
Xconomy | GlaxoSmithKline is providing as much as $465 million in startup funds for Avalon Ventures to invest in drug-discovery companies over the next three years.
|